HBK INVESTMENTS L P
Institutional investor · Portfolio as of Q2 2023
Top Holdings373 positions
SPDR S&P 500 ETF TR | 20.3M | $9B | 48.4% | — | — | — | Increased — |
SPDR S&P 500 ETF TR | 10.9M | $4.8B | 25.9% | — | — | — | Increased — |
HORIZON THERAPEUTICS PUB L | 6.1M | $622.2M | 3.3% | — | — | 3 qtrssince 2022-Q4 | Increased 59 |
NATIONAL INSTRS CORP | 6.5M | $371.9M | 2.0% | — | — | 1 qtr | New 71 |
UNIVAR SOLUTIONS INC | 7.7M | $276.1M | 1.5% | — | — | 1 qtr | New 70 |
VMWARE INC | 1.5M | $220.6M | 1.2% | — | — | 3 qtrssince 2022-Q4 | Increased 54 |
INVESCO QQQ TR | 476,000 | $175.8M | 0.9% | — | — | — | Increased — |
INVESCO QQQ TR | 463,700 | $171.3M | 0.9% | — | — | — | Increased — |
LIFE STORAGE INC | 1.1M | $146.3M | 0.8% | — | — | 1 qtr | New 59 |
PNM RES INC | 3M | $137.1M | 0.7% | $41.73 | -3.05% | 10 qtrssince 2021-Q1 | Decreased 0 |
SYNEOS HEALTH INC | 3.3M | $137M | 0.7% | — | — | 1 qtr | New 59 |
FOCUS FINL PARTNERS INC | 2.4M | $126.6M | 0.7% | — | — | 2 qtrssince 2023-Q1 | Increased 69 |
ACTIVISION BLIZZARD INC | 1.3M | $113M | 0.6% | — | — | 1 qtr | New 59 |
ISHARES TR | 534,300 | $100.1M | 0.5% | — | — | — | Increased — |
BROADCOM INC | 100,000 | $86.7M | 0.5% | — | — | — | New — |
IVERIC BIO INC | 2M | $78.7M | 0.4% | — | — | 1 qtr | New 49 |
SEAGEN INC | 400,000 | $77M | 0.4% | — | — | 1 qtr | New 49 |
| 38.2M | $76.1M | 0.4% | — | — | 2 qtrssince 2023-Q1 | Increased 45 | |
SILICON MOTION TECHNOLOGY CO | 800,000 | $57.5M | 0.3% | $64.35 | +3.17% | 4 qtrssince 2022-Q3 | Increased 57 |
ETF SER SOLUTIONS | 2.4M | $51.5M | 0.3% | — | — | — | Unchanged — |
HBK INVESTMENTS L P manages $18.6B across 373 positions as of Q2 2023. Top holdings: SPY puts (48.4%), SPY calls (25.9%), HZNP (3.3%). Fund DNA: Momentum Trader. HoldingsIntel Score: 2/5.0.
Active quarter - 114 new positions, 81 exits, 23 increased. Top move: NATI (NEW, conviction 71). Portfolio: $18.6B across 373 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR